New Insulin Bill UNVEILED – Government Overreach?
(USNewsBreak.com) – In a bipartisan effort, Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) pushed out legislation to help lower insulin costs on June 22. The two wish to bring together the parties to reach a final agreement that would limit companies from charging more than $35 to consumers who need the essential medication. In a joint statement, the senators urged Congress to move fast to pass the bill.
Bipartisan pair of senators unveils bill to lower insulin costs https://t.co/9N687Lu1bk pic.twitter.com/kJ114n3zfs
— The Hill (@thehill) June 22, 2022
Shaheen and Collins have been working for over a year to get legislation to a vote about this issue. They both feel strongly that people should not have to ration insulin or decide whether they can afford it when it’s necessary for their health.
However, there is pushback from some Republicans. The measure requires at least nine additional GOP senators to vote in favor of passing the bill. In the House version, there was little support, with some Republican representatives saying it was too close to controlling prices. The Senate bill is a bit broader than the one in the House, so the advocates hope it will gain more support. Shaheen and Collins aim to incentivize pharmaceutical companies to keep insulin prices low.
Senate Majority Leader Chuck Schumer vowed to call a vote on the bill and encourage GOP members to approve it.
Are price caps on insulin the right move? Should the government regulate pharmaceutical prices, or is it overreach?
Copyright 2022, USNewsBreak.com
